Rhythm Pharmaceuticals Announces Participation in Upcoming Bank of America Global Healthcare Conference
Rhythm Pharmaceuticals announced that its CEO, David Meeker, M.D., will participate in a fireside chat at the upcoming Bank of America Global Healthcare Conference on May 13, 2026. The company is a commercial-stage biopharmaceutical firm focused on rare neuroendocrine diseases and markets IMCIVREE® (setmelanotide), a treatment for certain genetic o…